Imlygic Injection, Suspension
Product Images NDC 55513-079

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Imlygic (NDC 55513-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Injection Administration For Cutaneous Lesions (Imlygic 01)

Figure 1: Injection Administration For Cutaneous Lesions (Imlygic 01)
FDA Label Image

Figure 2: Injection Administration For Subcutaneous Lesions (Imlygic 02)

Figure 2: Injection Administration For Subcutaneous Lesions (Imlygic 02)
FDA Label Image

Figure 3: Injection Administration For Nodal Lesions (Imlygic 03)

Figure 3: Injection Administration For Nodal Lesions (Imlygic 03)
FDA Label Image

Figure 4: Single-use Vial Permanently Inserted Into A Clear Copolyester Plastic Sleeve (Imlygic 04)

Figure 4: Single-use Vial Permanently Inserted Into A Clear Copolyester Plastic Sleeve (Imlygic 04)
FDA Label Image

Figure 5: Single-use Vial Without A Clear Plastic Sleeve (Imlygic 05)

Figure 5: Single-use Vial Without A Clear Plastic Sleeve (Imlygic 05)
FDA Label Image

Imlygic 06

Imlygic 06
This is a description of a medication called IMLYGIC, which comes in a 10¢ PFU/mL Single Use Vial consisting of 1 mL of deliverable containing 10 plaque forming units (PFU), meant for intralesional injection. It is a Suspension for Injection made of lumefantrine and d-sodium bydrogen phosphate dihydrate, with no preservatives and packaged in a natural rubber latex-free container. The text also provides storage instructions for this medication.*
FDA Label Image

Principal Display Panelstore At -70⁰c To -90⁰c (-94⁰f To -130⁰f)talimogene Laherparepvec106 Pfu/ml106 Pfu/mlfor Intralesional Injection Onlybiovex, Inc., A Subsidiary Of Amgen Inc.,one Amgen Center Drive, Thousand Oaks, California 91320-1799rx Onlylot:exp.: (Imlygic 07)

Principal Display Panelstore At -70⁰c To -90⁰c (-94⁰f To -130⁰f)talimogene Laherparepvec106 Pfu/ml106 Pfu/mlfor Intralesional Injection Onlybiovex, Inc., A Subsidiary Of Amgen Inc.,one Amgen Center Drive, Thousand Oaks, California 91320-1799rx Onlylot:exp.: (Imlygic 07)
This appears to be a medication guide and package insert for a drug called IMLYGIC®. It is a suspension for injection containing talimogene laherparepvec at a concentration of 10 PFU/mL and 10 PRU/mL in a single-use vial. The drug is not meant to be diluted and must be stored at a certain temperature range. Detailed prescription information and instructions are available in the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.